Association between polymorphism of the cholecystokinin gene and idiopathic Parkinson's disease
- 1 November 1999
- journal article
- research article
- Published by Wiley in Clinical Genetics
- Vol. 56 (5), 395-400
- https://doi.org/10.1034/j.1399-0004.1999.560508.x
Abstract
Parkinson's disease (PD) is characterized by major alterations of neurotransmitter activity due to damage of the substantia nigra. Changes in neuropeptide concentration within the basal ganglia may play an important role in the putative dopaminergic–peptidergic interactions associated with the disease. Cholecystokinin (CCK) modulates the release of dopamine in the mesolimbic pathway and affects dopamine‐related behavior.We analyzed genetic variations in the CCK gene, in both the coding and promoter region, in order to investigate the role of polymorphism in idiopathic PD. Four polymorphic sites of the CCK gene (‐196G/A, ‐45C/T, 1270C/G, 6662C/T) were found in PD patients and controls. Complete linkage disequilibrium was observed between the ‐45 locus and the 1270 locus, and also a possible linkage disequilibrium was found between the ‐45 and ‐196 loci. A significant difference was found in the distributions of three identified genotypes at the ‐45 locus between 116 PD patients and 95 age‐matched control subjects (χ2=7.95, p=0.018, Bonferroni correction; p=0.054). In addition, a significant difference was obtained amongst the three genotypic groups at the ‐45 locus when compared between PD patients who experienced hallucinations (n=23) and those (n=93) who did not (χ2=8.08, p=0.018, Bonferroni correction; p=0.126).Our data suggested that mutations at the ‐45 locus in the promoter region of the CCK gene may influence vulnerability to hallucinations in PD patients treated with l‐dopa.Keywords
This publication has 26 references indexed in Scilit:
- A New Genetic Variant in the Sp1 Binding Cis-Element of Cholecystokinin Gene Promoter Region and Relationship to AlcoholismAlcohol, Clinical and Experimental Research, 1998
- Mutation in the α-Synuclein Gene Identified in Families with Parkinson's DiseaseScience, 1997
- Transcriptional Regulation of the Human Cholecystokinin Gene: Composite Action of Upstream Stimulatory Factor, Sp1, and Members of the CREB/ATF-AP-1 Family of Transcription FactorsDNA and Cell Biology, 1996
- Isolation of a novel cDNA encoding a zinc-finger protein that binds to two sites within the c-myc promoterBiochemistry, 1992
- Cholecystokinin-dopamine intearctionsTrends in Pharmacological Sciences, 1991
- Cholecystokinin Modulates the Release of Dopamine from the Anterior and Posterior Nucleus Accumbens by Two Different MechanismsJournal of Neurochemistry, 1991
- Variability of changes in obese rat brain monoamines in response to cholecystokininGeneral Pharmacology: The Vascular System, 1986
- Peptides and Parkinson's diseaseTrends in Neurosciences, 1985
- Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction.JCI Insight, 1985
- Peptidergic neuronesNature, 1980